Blogger

Help us write news and opinion content for #MEAction and join a vibrant community of patient activists.

Description: #MEAction’s volunteer bloggers develop their own stories and write content ideas suggested by the MEAction team.

We are looking for folks who can write on any topics but are especially interested in covering science and policy.

We are committed to developing a deep bench of bloggers from diverse countries. Currently we have capacity for English only but would love to talk to anyone interested in writing in their native language or in translating existing content into their native language.

We prefer that bloggers write under their own names but it is possible to write anonymously for those who need to protect their anonymity.

Skills: Strong writing skills.

Hours: Bloggers can contribute as much or as little as they are able. Plus: able to commit to one article a week.

Pay: Volunteer basis.

Facebook
Twitter
WhatsApp
Email

Latest News

Blue square image with starbursts in the corners. the words, submit long covid drug recommendations to recover -tlc! are in the middle of the image, surrounded by thin white lines. the meaction logo is at the top of the image.

Submit Long COVID Drug Recommendations to RECOVER-TLC!

Last month, RECOVER TLC met at NIH headquarters in Bethesda. The goal was to initiate a drug development strategy for Long COVID clinical trials. Now, RECOVER TLC has opened the RECOVER-TLC Intervention Information Request Form, where you can make suggestions about which drugs and other interventions to trial!  Anyone can submit a therapeutic for consideration

Read More »
A classroom of people watching a panel discussion.

The RECOVER-Treating Long COVID (RECOVER TLC) The Path Forward

The RECOVER-Treating Long COVID (RECOVER TLC) Kick-off Meeting was Sept 23-25 in person and over Zoom. I had the privilege of attending over Zoom and Jaime Seltzer, #MEAction’s Scientific Director, represented the needs of the ME community in person and as an invited member of a panel on clinical trial design. There were many speakers

Read More »
Scroll to Top